Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Prime Medicine Inc (PRME)
Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 816,548
  • Shares Outstanding, K 97,324
  • Annual Sales, $ 0 K
  • Annual Income, $ -121,820 K
  • 60-Month Beta 1.19
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.05
Trade PRME with:

Options Overview Details

View History
  • Implied Volatility 68.43% ( +6.81%)
  • Historical Volatility 95.45%
  • IV Percentile 23%
  • IV Rank 31.43%
  • IV High 214.57% on 10/17/23
  • IV Low 1.45% on 03/22/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 4
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 2,037
  • Open Int (30-Day) 1,992

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.52
  • Number of Estimates 4
  • High Estimate -0.46
  • Low Estimate -0.55
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.07 +41.02%
on 11/16/23
8.63 -0.81%
on 12/07/23
+0.25 (+3.01%)
since 11/07/23
3-Month
5.54 +54.51%
on 10/27/23
13.27 -35.51%
on 09/13/23
-3.76 (-30.55%)
since 09/07/23
52-Week
5.54 +54.51%
on 10/27/23
21.48 -60.14%
on 02/03/23
-8.30 (-49.23%)
since 12/07/22

Most Recent Stories

More News
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 70.21 (-1.31%)
BEAM : 28.75 (+0.28%)
CRBU : 5.95 (+0.17%)
EDIT : 10.90 (-1.89%)
NTLA : 29.78 (-0.27%)
PRME : 8.56 (+2.03%)
VERV : 12.91 (+3.36%)
LLY : 588.27 (-0.17%)
REGN : 849.18 (+1.61%)
VRTX : 353.95 (+0.14%)
ARKG : 28.71 (+0.35%)
HOOD : 11.48 (+1.86%)
1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years

This gene-editing company could sport a best-in-class platform.

PRME : 8.56 (+2.03%)
ARKG : 28.71 (+0.35%)
2 Cathie Wood Stocks That Could Be Hidden Gems

These two biotech stocks could deliver life-altering returns for long-term investors.

PRME : 8.56 (+2.03%)
DNA : 1.3300 (+2.31%)
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought

There are always stocks to buy if you're Ark Invest's ace stock picker.

CRWD : 240.17 (+0.31%)
PRME : 8.56 (+2.03%)
ADPT : 4.66 (+0.87%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

There are always stocks to buy if you're Ark Invest's ace stock picker.

PATH : 23.41 (+0.21%)
PRME : 8.56 (+2.03%)
ADPT : 4.66 (+0.87%)
3 Low-Rated Stocks Could See Short Squeezes

Nowadays, investors keep a close watch on potential short squeezes, as several short squeezes in the recent past have helped many generate outsized returns. Potential short candidates Prime Medicine (PRME),...

AMC : 6.82 (+0.44%)
BBBY : 0.0751 (-27.09%)
GME : 16.36 (+10.24%)
PRME : 8.56 (+2.03%)
SOLO : 0.3940 (+0.31%)
TTCF : 0.1580 (-24.76%)
Prime Medicine Announces Pricing of Upsized Initial Public Offering

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of its upsized initial...

PRME : 8.56 (+2.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 9.16
2nd Resistance Point 8.89
1st Resistance Point 8.73
Last Price 8.56
1st Support Level 8.30
2nd Support Level 8.03
3rd Support Level 7.87

See More

52-Week High 21.48
Fibonacci 61.8% 15.39
Fibonacci 50% 13.51
Fibonacci 38.2% 11.63
Last Price 8.56
52-Week Low 5.54

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar